Ramsay Health Care (FRA:RMY) Other Current Receivables: €-106 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:RMY Ramsay Health Care Ltd FRA:RMY
80 GF Score
Price €31.20
GF Value €24.84
! 9 Warning Signs
View Full Analysis

What is Ramsay Health Care Other Current Receivables?

Ramsay Health Care FRA:RMY +1.96% 80 Other Current Receivables is €-106 Mil as of Jun. 2026. GuruFocus rates FRA:RMY with a GF Score™ of 80/100 and a GF Value™ of €24.84. The stock has 9 warning signs investors should review.

Ramsay Health Care's Other Current Receivables for the quarter that ended in Jun. 2026 was €-106 Mil.

Ramsay Health Care's quarterly Other Current Receivables increased from Jun. 2025 (€-109.96 Mil) to Dec. 2025 (€0.00 Mil) but then stayed the same from Dec. 2025 (€0.00 Mil) to Jun. 2026 (€-105.89 Mil).

Ramsay Health Care's annual Other Current Receivables declined from Jun. 2024 (€-95.86 Mil) to Jun. 2025 (€-109.96 Mil) but then increased from Jun. 2025 (€-109.96 Mil) to Jun. 2026 (€-105.89 Mil).

Ramsay Health Care Other Current Receivables Related Terms

Ramsay Health Care Other Current Receivables Historical Data

* Premium members only.

The historical data trend for Ramsay Health Care's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ramsay Health Care Other Current Receivables Chart

Ramsay Health Care Annual Data
Trend Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25 Jun26
Other Current Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only -46.94 -80.96 -95.86 -109.96 -105.89

Ramsay Health Care Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Other Current Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -95.86 0.00 -109.96 0.00 -105.89
FRA:RMY
80GF Score
Ramsay Health Care Ltd FRA:RMY
Other Current Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ramsay Health Care Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

What does a Other Current Receivables of €-106 Mil mean?
Ramsay Health Care (FRA:RMY) has a Other Current Receivables of €-106 Mil as of Jun. 2026. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Ramsay Health Care and its competitors.
Is Ramsay Health Care's Other Current Receivables too high?
Ramsay Health Care's current Other Current Receivables is €-106 Mil. Overall, Ramsay Health Care has a GF Score™ of 80/100, reflecting its overall financial health beyond just this single metric.
How does Ramsay Health Care's Other Current Receivables compare to HCA and THC?
Ramsay Health Care's Other Current Receivables of €-106 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Receivables for a Healthcare Providers & Services company?
A good Other Current Receivables depends on the Healthcare Providers & Services industry context. However, Other Current Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Receivables mean?
A high Other Current Receivables can signal that a stock is expensive relative to its fundamentals. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Ramsay Health Care and its competitors. Ramsay Health Care's current Other Current Receivables is €-106 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ramsay Health Care stock overvalued right now?
Ramsay Health Care (FRA:RMY) has a current Other Current Receivables of €-106 Mil. The stock's GF Value™ is €24.84, compared to a current price of €31.20 — trading 25.6% above its estimated fair value. The current Other Current Receivables is €-106 Mil. Ramsay Health Care's overall GF Score™ is 80/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Receivables calculated?
Other Current Receivables is calculated from a company's financial statements. For Ramsay Health Care (FRA:RMY), the current Other Current Receivables is €-106 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ramsay Health Care (FRA:RMY) Overvalued in 2026?

Based on GuruFocus' analysis, Ramsay Health Care stock appears to be overvalued. The current stock price of €31.20 is trading 25.6% above its estimated GF Value™ of €24.84.

Key valuation signals for FRA:RMY:

  • Other Current Receivables: €-106 Mil
  • GF Value™: €24.84 vs. price of €31.20 (25.6% above fair value)
  • GF Score™: 80/100 with 9 warning signs

No single metric tells the full story. See the FRA:RMY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Ramsay Health Care Business Description

Address 126 Phillip Street, Suite 18.03, Level 18, Deutsche Bank Place, Sydney, NSW, AUS, 2000
Ramsay Health Care is one of the largest private healthcare providers in the world, with more than 500 sites across about eight countries. The key markets in which it operates are Australia, France, the UK, and Sweden. It is the largest private hospital group in each of these markets except for the UK, where it is the largest independent supplier to the NHS. Ramsay Santé, which operates the European regions other than the UK, is a 53%-owned subsidiary of Ramsay Health Care. The company typically earns about two-thirds of consolidated earnings in Australia. Ramsay Health Care undertakes both private and publicly funded healthcare.
80GF Score

Get the complete analysis for FRA:RMY

Other Current Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€31.20
Price
€24.84
GF Value